Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1998-5-27
pubmed:abstractText
Anecdotal reports have suggested that systemic chemotherapy with agents that better cross the blood-brain barrier may result in long term disease remission in some patients with central nervous system (CNS) lymphoma. This treatment strategy has the advantage of sparing patients the late neurologic complications from brain irradiation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
82
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1946-51
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9587129-Adult, pubmed-meshheading:9587129-Aged, pubmed-meshheading:9587129-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:9587129-Carmustine, pubmed-meshheading:9587129-Central Nervous System Neoplasms, pubmed-meshheading:9587129-Disease Progression, pubmed-meshheading:9587129-Etoposide, pubmed-meshheading:9587129-Female, pubmed-meshheading:9587129-Humans, pubmed-meshheading:9587129-Lymphoma, AIDS-Related, pubmed-meshheading:9587129-Male, pubmed-meshheading:9587129-Methotrexate, pubmed-meshheading:9587129-Methylprednisolone Hemisuccinate, pubmed-meshheading:9587129-Middle Aged, pubmed-meshheading:9587129-Pilot Projects, pubmed-meshheading:9587129-Prospective Studies, pubmed-meshheading:9587129-Survival Rate, pubmed-meshheading:9587129-Treatment Outcome, pubmed-meshheading:9587129-Vincristine
pubmed:year
1998
pubmed:articleTitle
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol.
pubmed:affiliation
Department of Internal Medicine, National Taiwan University Hospital, Taipei.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't